Deutsche Bank
VRNA

Deutsche Bank’s Verona Pharma VRNA Stock Holding History

Deutsche Bank’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-59
Closed – – 4437
2021
Q3 		$0 Buy
59
+1
+2% +$6 ﹤0.01% 4708
2021
Q2 		$0 Buy
+58
New +$402 ﹤0.01% 4823
2021
Q1 		– Sell
-117
Closed -$1K – 4687
2020
Q4 		$1K Buy
+117
New +$790 ﹤0.01% 4390
2020
Q1 		– Sell
-442
Closed -$2K – 4859
2019
Q4 		$2K Buy
442
+68
+18% +$297 ﹤0.01% 4857
2019
Q3 		$1K Sell
374
-9,900
-96% -$44.2K ﹤0.01% 4821
2019
Q2 		$52K Sell
10,274
-1,400
-12% -$8.54K ﹤0.01% 4497
2019
Q1 		$75K Buy
11,674
+5,500
+89% +$35.8K ﹤0.01% 4417
2018
Q4 		$55K Sell
6,174
-243
-4% -$2.76K ﹤0.01% 4448
2018
Q3 		$80K Sell
6,417
-50
-0.8% -$645 ﹤0.01% 4575
2018
Q2 		$88K Buy
6,467
+4,766
+280% +$80.1K ﹤0.01% 4593
2018
Q1 		$34K Buy
1,701
+1,101
+184% +$15.9K ﹤0.01% 4872
2017
Q4 		$7K Buy
+600
New +$7.79K ﹤0.01% 4821

Other funds holding VRNA

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return